EVOME MEDICAL TECHNOLOGIES INC. Quarterly Depreciation, Depletion and Amortization in CAD from Q2 2021 to Q1 2023

Taxonomy & unit
us-gaap: CAD
Description
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Summary
Evome Medical Technologies Inc. annual/quarterly Depreciation, Depletion and Amortization history and growth rate from Q2 2021 to Q1 2023.
  • Evome Medical Technologies Inc. Depreciation, Depletion and Amortization for the quarter ending March 31, 2023 was CA$917K, a 147% increase year-over-year.
  • Evome Medical Technologies Inc. annual Depreciation, Depletion and Amortization for 2023 was CA$1M.
  • Evome Medical Technologies Inc. annual Depreciation, Depletion and Amortization for 2021 was CA$842K.
Depreciation, Depletion and Amortization, Quarterly (CAD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 917K +546K +147% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q2 2022 413K +396K +2377% Mar 1, 2022 May 31, 2022 10-Q 2022-07-15
Q1 2022 371K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q2 2021 16.7K Mar 1, 2021 May 31, 2021 10-Q 2022-07-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.